No photo of Mary Eugenia Rinella

View Scopus Profile

Mary Eugenia Rinella

  • 4831 Citations
20012020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Certifications and Licenses

Transplant Hepatology
Gastroenterology

Training Experience

1999Residency, University of Chicago Hospitals
2002Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital)

Education/Academic qualification

MD, University of Illinois at Chicago

… → 1996

Research interests

  • Colonoscopy
  • Esophagogastroduodenoscopy (EGD)
  • Hepatitis
  • Liver Biopsy
  • Liver/Hepatic Disease
  • Non-Alcoholic Fatty Liver Disease
  • Variceal Banding
  • Viral Hepatitis

Fingerprint Dive into the research topics where Mary Eugenia Rinella is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

Prot#VK2809-202: A Phase 2B, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of VK2809 Administered for 52 Weeks Followed by a 4-Week Off-Drug Phase in Subjects with Biopsy Proven Non-Alcoh

Rinella, M. E.

Covance Inc., Viking Therapeutics, Inc.

3/4/20 → 3/4/23

Project: Research project

Prot# Aramchol-018: A Phase 3/4, Multinational, Multicenter, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects with Nonalcoholic Steatohepatitis (NASH)

Rinella, M. E.

Covance Inc., Galmed Research and Development Ltd.

12/23/19 → 12/23/23

Project: Research project

Prot# MGL-3196-11: A Phase 3, Multinational, Double-Blind, Randomized, Placebo-Controlled Study of MGL-3196 (resmetirom) in Patients With Non-Alcoholic Steatohepatitis (NASH) and Fibrosis to Resolve NASH and Reduce Progression to Cirrhosis and/or Hepatic

Rinella, M. E.

Pharmaceutical Research Associates, Inc., Madrigal Pharmaceuticals, Inc.

12/20/19 → 12/20/22

Project: Research project

Prot#18-0108: A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy, Safety, and Tolerability of Two Doses of NGM282 Administered for 24 Weeks for the Treatment of Histologically Confirmed Nonalcoholic Steat

Rinella, M. E.

Medpace Clinical Research LLC, NGM Biopharmaceuticals, Inc.

8/23/19 → 8/23/22

Project: Research project

Metabolic biomarkers as predictors of Nash recurrence after liver transplant

Rinella, M. E.

American College of Gastroenterology

7/1/19 → 12/31/21

Project: Research project

    • Research Output

    A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial

    Pedrosa, M., Seyedkazemi, S., Francque, S., Sanyal, A., Rinella, M., Charlton, M., Loomba, R., Ratziu, V., Kochuparampil, J., Fischer, L., Vaidyanathan, S. & Anstee, Q. M., Jan 2020, In : Contemporary Clinical Trials. 88, 105889.

    Research output: Contribution to journal › Article

    Open Access
    • 4 Scopus citations

    Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension

    The Belapectin (GR-MD-02) Study Investigators, Apr 2020, In : Gastroenterology. 158, 5, p. 1334-1345.e5

    Research output: Contribution to journal › Article

    Open Access
    • 7 Scopus citations

    Longitudinal Association of Non-Alcoholic Fatty Liver Disease With Changes in Myocardial Structure and Function: The CARDIA Study

    VanWagner, L. B., Wilcox, J. E., Ning, H., Lewis, C. E., Carr, J. J., Rinella, M. E., Shah, S. J., Lima, J. A. C. & Lloyd-Jones, D. M., Feb 18 2020, In : Journal of the American Heart Association. 9, 4, e014279.

    Research output: Contribution to journal › Article

    Open Access
    • 2 Scopus citations

    MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease

    International Consensus Panel, May 2020, In : Gastroenterology. 158, 7, p. 1999-2014.e1

    Research output: Contribution to journal › Article

    • 31 Scopus citations

    Nonalcoholic Fatty Liver Disease 2020: The State of the Disease

    Cotter, T. G. & Rinella, M., May 2020, In : Gastroenterology. 158, 7, p. 1851-1864 14 p.

    Research output: Contribution to journal › Article

    • 10 Scopus citations